CVEvulnerability
CVE-2024-1706
2.0 LOW
Official page ↗
- Status
- Modified
- Published
- 2024-02-21
- Last modified
- 2026-06-17
- Assigner
- [email protected]
- CVSS 4.0 ([email protected])
- 2.0 LOW — CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
- CVSS 3.1 ([email protected])
- 3.5 LOW — CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N
- CVSS 3.1 ([email protected])
- 5.4 MEDIUM — CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
- CVSS 2.0 ([email protected])
- 4.0 MEDIUM — AV:N/AC:L/Au:S/C:N/I:P/A:N
- Weaknesses
- CWE-79, CWE-94
Description
A vulnerability was determined in ZKTeco ZKBio Access IVS up to 3.3.2. This impacts an unknown function of the component Department Name Search Bar. This manipulation with the input <marquee>hi causes cross site scripting. Remote exploitation of the attack is possible. The exploit has been publicly disclosed and may be utilized. The vendor explains: "ZKBio Access IVS is no longer maintained and the product has been replaced by ZKBio CVAccess, it is recommended to replace it with the latest version of ZKBio CVAccess." This vulnerability only affects products that are no longer supported by the maintainer.
Affected configurations
• zkteco zkbio access ivs (<= 3.3.2)
Related
References
- https://gist.githubusercontent.com/whiteman007/8d3a09991de4ef336937ba91c07b7856/raw/adc00538d7a8c3c54bde4797a10d9b6af393711d/gistfile1.txt Third Party Advisory
- https://vuldb.com/?ctiid.254396 Permissions Required
- https://vuldb.com/?id.254396 Third Party Advisory
- https://vuldb.com/?submit.280083 vuldb.com
- https://vuldb.com/?submit.280084 vuldb.com
- https://www.zkteco.com/en/Security_Bulletinsibs/21 www.zkteco.com
- https://gist.githubusercontent.com/whiteman007/8d3a09991de4ef336937ba91c07b7856/raw/adc00538d7a8c3c54bde4797a10d9b6af393711d/gistfile1.txt Third Party Advisory
- https://vuldb.com/?ctiid.254396 Permissions Required
- https://vuldb.com/?id.254396 Third Party Advisory